MARVELON

This brand name is authorized in Austria, Canada, Ecuador, Estonia, Hong Kong, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug MARVELON contains a combination of these active pharmaceutical ingredients (APIs):

1 Desogestrel UNII 81K9V7M3A3 - DESOGESTREL

Desogestrel is a progestogen. Like other progestogen-only pills, desogestrel is best suited for use during breast feeding and for women who may not or do not want to use oestrogens. In contrast to traditional progestogen-only pills, the contraceptive effect of desogestrel is achieved primarily by inhibition of ovulation. Other effects include increased viscosity of the cervical mucus. Read about Desogestrel

2 17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. Read about 17 alpha-Ethinylestradiol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MARVELON Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AA09	Desogestrel and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02042479, 02042487
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.160-05-03
Country: EE	Ravimiamet	Identifier(s): 1062852, 1062863
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 175695, 185917, 26205
Country: HK	Department of Health Drug Office	Identifier(s): 28591
Country: JP	医薬品医療機器総合機構	Identifier(s): 254910CF1025, 254910CF2021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010380, 1014664, 1065683, 1082481, 1084742
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 298M87
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 39578
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100040953, 100127281, 100257517, 100269704, 100289859, 100335217, 100343955, 100346238, 100347060, 100347309, 100388892, 100423217, 100429734, 100443763
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68117001, W68117002